(Q53928507)

22 May 2018

title

Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. (English)

1 reference

22 May 2018

metabolic dysfunction–associated steatotic liver disease

1 reference

1 reference

1 reference

1

1 reference

22 May 2018

Anna L. Fracanzani

3

1 reference

22 May 2018

author name string

P Dongiovanni

2

1 reference

22 May 2018

G Santorelli

4

1 reference

22 May 2018

E Fatta

5

1 reference

22 May 2018

C Bertelli

6

1 reference

22 May 2018

E Taioli

7

1 reference

22 May 2018

G Fiorelli

8

1 reference

22 May 2018

S Fargion

9

1 reference

22 May 2018

publication date

1 March 2003

1 reference

22 May 2018

Digestive and Liver Disease

published in

1 reference

22 May 2018

volume

35

1 reference

22 May 2018

issue

3

1 reference

22 May 2018

page(s)

172-178

1 reference

22 May 2018

Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Serum ferritin as a component of the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Insulin resistance-associated hepatic iron overload.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Effect of phlebotomy on plasma glucose and insulin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Insulin resistance in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Fatty liver--an additional and treatable feature of the insulin resistance syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Nonalcoholic Steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Gluconate metabolism of Pasteurellapestis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Measurement of liver-iron concentration in needle-biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

The homeostasis model in the San Antonio Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Regulation of ferritin genes and protein

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

Venesection therapy of insulin resistance-associated hepatic iron overload

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900025-2

7 January 2021

10.1016/S1590-8658(03)00025-2

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018